Quantum Computing for the Pharmaceutical Industry

A new report from Enter Quantum explains how quantum computers could hold the key to finding new ways of assembling molecules to create novel medications.

The human body’s reaction to a disease involves complex interactions between many proteins. Pharmaceutical companies conduct drug development by identifying a target and finding potential candidate medicines, a process that can take up to four years.

Synthesizing potential future medicines requires many interrelated calculations involving complex molecules, which classical computers struggle with. Current gate-based quantum computers are not yet powerful enough to tackle the problem beyond very small molecules.

Read full report at Enter Quantum.